|
1
|
Fushida S, Kinoshita J, Yagi Y, et al:
Dual anti-cancer effects of weekly intraperitoneal docetaxel in
treatment of advanced gastric cancer patients with peritoneal
carcinomatosis: A feasibility and pharmacokinetic study. Oncol Rep.
19:1305–1310. 2008.
|
|
2
|
Yonemura Y, Elnemr A, Endou Y, et al:
Multidisciplinary therapy for treatment of patients with peritoneal
carcinomatosis from gastric cancer. World J Gastrointest Oncol.
2:85–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
|
|
4
|
Tlsty TD: Stromal cells can contribute
oncogenic signals. Semin Cancer Biol. 11:97–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeisberg EM, Potenta S, Xie L, Zeisberg M
and Kalluri R: Discovery of endothelial to mesenchymal transition
as a source for carcinoma-associated fibroblasts. Cancer Res.
67:10123–10128. 2007.PubMed/NCBI
|
|
6
|
Pietras K and Ostman A: Hallmarks of
cancer: interactions with the tumor stroma. Exp Cell Res.
316:1324–1331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447.
2003.PubMed/NCBI
|
|
8
|
Yashiro M, Chung YS and Sowa M: Role of
orthotopic fibroblasts in the development of scirrhous gastric
carcinoma. Jpn J Cancer Res. 85:883–886. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Semba S, Kodama Y, Ohnuma K, et al: Direct
cancer-stromal interaction increases fibroblast proliferation and
enhances invasive properties of scirrhous-type gastric carcinoma
cells. Br J Cancer. 101:1365–1373. 2009. View Article : Google Scholar
|
|
10
|
Nakazawa K, Yashiro M and Hirakawa K:
Keratinocyte growth factor produced by gastric fibroblasts
specifically stimulates proliferation of cancer cells from
scirrhous gastric carcinoma. Cancer Res. 63:8848–8852. 2003.
|
|
11
|
Elenbaas B and Weinberg RA: Heterotypic
signaling between epithelial tumor cells and fibroblasts in
carcinoma formation. Exp Cell Res. 264:169–184. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Durning P, Schor SL and Sellwood RA:
Fibroblasts from patients with breast cancer show abnormal
migratory behaviour in vitro. Lancet. 2:890–892. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schor SL, Schor AM, Grey AM and Rushton G:
Foetal and cancer patient fibroblasts produce an autocrine
migration-stimulating factor not made by normal adult cells. J Cell
Sci. 90:391–399. 1988.PubMed/NCBI
|
|
14
|
Grünert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665.
2003.PubMed/NCBI
|
|
15
|
Brenmoehl J, Miller SN, Hofmann C, et al:
Transforming growth factor-beta 1 induces intestinal myofibroblast
differentiation and modulates their migration. World J
Gastroenterol. 15:1431–1442. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andersson-Sjöland A, Erjefält JS, Bjermer
L, Eriksson L and Westergren-Thorsson G: Fibrocytes are associated
with vascular and parenchymal remodelling in patients with
obliterative bronchiolitis. Respir Res. 10:1032009.PubMed/NCBI
|
|
17
|
Tahara E: Abnormal growth factor/cytokine
network in gastric cancer. Cancer Microenviron. 1:85–91. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshida K, Yokozaki H, Niimoto M, Ito H,
Ito M and Tahara E: Expression of TGF-beta and procollagen type I
and type III in human gastric carcinomas. Int J Cancer. 44:394–398.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wells RG: Fibrogenesis. V: TGF-beta
signaling pathways. Am J Physiol Gastrointest Liver Physiol.
279:G845–850. 2000.PubMed/NCBI
|
|
20
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor beta in human disease. N Engl J Med.
342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang XY, Pettengell R, Nasiri N, Kalia V,
Dalgleish AG and Barton DP: Characteristics and growth patterns of
human peritoneal mesothelial cells: comparison between advanced
epithelial ovarian cancer and non-ovarian cancer sources. J Soc
Gynecol Investig. 6:333–340. 1999.
|
|
24
|
Jayne DG, Perry SL, Morrison E, Farmery SM
and Guillou PJ: Activated mesothelial cells produce heparin-binding
growth factors: implications for tumour metastases. Br J Cancer.
82:1233–1238. 2000.PubMed/NCBI
|
|
25
|
Kajiyama H, Shibata K, Ino K, Nawa A,
Mizutani S and Kikkawa F: Possible involvement of
SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of
migratory potential in human peritoneal mesothelial cells. Cell
Tissue Res. 330:221–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aroeira LS, Aguilera A, Sánchez-Tomero JA,
et al: Epithelial to mesenchymal transition and peritoneal membrane
failure in peritoneal dialysis patients: pathologic significance
and potential therapeutic interventions. J Am Soc Nephrol.
18:2004–2013. 2007. View Article : Google Scholar
|
|
27
|
Nishimura S, Chung YS, Yashiro M, Inoue T
and Sowa M: Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in
the peritoneal implantation of scirrhous gastric carcinoma. Br J
Cancer. 74:1406–1412. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yung S, Li FK and Chan TM: Peritoneal
mesothelial cell culture and biology. Perit Dial Int. 26:162–173.
2006.PubMed/NCBI
|
|
29
|
Yashiro M, Chung YS, Nishimura S, Inoue T
and Sowa M: Peritoneal metastatic model for human scirrhous gastric
carcinoma in nude mice. Clin Exp Metastasis. 14:43–54. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yashiro M, Chung YS, Inoue T, et al:
Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts
may affect mesothelial cell morphology and promote peritoneal
dissemination. Int J Cancer. 67:289–293. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang S, Pham LK, Liao CP, Frenkel B, Reddi
AH and Roy-Burman P: A novel bone morphogenetic protein signaling
in heterotypic cell interactions in prostate cancer. Cancer Res.
68:198–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yasumoto K, Koizumi K, Kawashima A, et al:
Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of
gastric cancer. Cancer Res. 66:2181–2187. 2006. View Article : Google Scholar : PubMed/NCBI
|
